Oscar Ö. Braun

Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease

Lars Wallentin, Christoph Varenhorst, Stefan James et al. · European Heart Journal · 2007 · 455 citations · Full text

Medicine, Cardiology, Pharmacology +17

Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction

Ola Vedin, Carolyn S.P. Lam, Angela S. Koh et al. · Circulation Heart Failure · 2017 · 287 citations

Medicine, Cardiology, Internal Medicine +10

Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction

Enrico Ammirati, Giacomo Veronese, Michela Brambatti et al. · Journal of the American College of Cardiology · 2019 · 274 citations

Medicine, Cardiology, Internal Medicine +11

Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease

Christoph Varenhorst, Stefan James, David Erlinge et al. · European Heart Journal · 2009 · 267 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Improving Risk Prediction in Heart Failure Using Machine Learning

Eric Adler, Adriaan A. Voors, Liviu Klein et al. · European Journal of Heart Failure · 2019 · 238 citations · Full text

Computing, Cardiology, Health Informatics +16